Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    Thrombotic thrombocytopenic purpura OR Upshaw-Schulman syndrome OR Moschcowitz disease | Open Studies | NIH, U.S. Fed
Show Display Options
Rank Status Study
1 Recruiting Low Dose Rituximab in Thrombotic Thrombocytopenic Purpura
Condition: Thrombotic Thrombocytopenic Purpura
Intervention: Biological: rituximab

Study has passed its completion date and status has not been verified in more than two years.